The Drug (Prices Control) Order implemented in May last year brought into its purview 652 packs of 348 formulations.
The company did not respond to specific queries on the project's expansion.
The agreement says UB Group and Adventz will have the right of first refusal over each other's shares.
Even smaller companies like Torrent Pharma and Alembic file five to 10 ANDAs every year.
Poddar had earlier said he would sell his stake in Mangalore Chemicals to the highest bidder.
Experts say despite it being a global deal, the transaction will have to undergo CCI scrutiny because of the scale of operations.
On Tuesday, Novartis agreed to buy GSK's oncology products business for $14.5 billion, while selling its vaccines business, excluding flu, to GSK for $7.1 billion.
ICAI has also imposed a fine of Rs 5 lakh on each of the three accused in Satyam case.
The company buys distressed assets across the globe and turns them around to not only add to its books but also its product pipeline and regions.
The NPPA letter was issued to GSK on Wednesday.
Apart from Wockhardt, only Biocon manufactures insulin analog indigenously.
What started as a mere payment delay seems to have grown into a tussle between the government and leading private hospitals, empanelled under the Central Government Health Scheme.
Legal experts and official sources said the alleged submission of fake documents can also lead to criminal charges against Novartis.
Indian traveller is no longer satisfied with a single annual vacation, but is increasingly demanding multiple holidays and festive breaks offer an ideal opportunity.
Bankers of HPL too have endorsed the idea and are pitching hard for the chairmanship of Chatterjee.
The US Food and Drug Administration has asked USV to probe employees who might have been responsible for inaccurate data reporting.
CCI has accused realty player DLF of preparing one-sided agreement with home buyers
Whistle-blower Dinesh Thakur will speak on Made-in-India drugs at an event in Washington.
Swiss drug maker Novartis might face tough action from the country's drug regulator for allegedly giving fake documents while seeking renewal of registration for Tiamulin Hydrogen Fumerate (80 per cent granules), sources said.
Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.